[The possibility of using sulprostone during laparoscopic myomectomy in uterine fibromyomatosis. Preliminary studies].
The authors considered sulprostone effects, PGE2 synthetic derivative, on the hematic loss during laparomyomectomy. This drug is been used by intravenous way during the operation in 84 patients affected with uterine myomatosis. The effectiveness and tolerance of the drug is thus evident in the reduction of the hematic intraoperative loss.
Baldoni
A
A
Cattedra di Ginecologia e Ostetricia, Università degli Studi di Perugia.
Moscioni
P
P
Colonnelli
M
M
Affronti
G
G
Gilardi
G
G
D000328:Adult; D016063:Blood Loss, Surgical / Q000517:prevention & control; D015232:Dinoprostone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007430:Intraoperative Care; D010535:Laparoscopy; D018231:Leiomyomatosis / Q000097:blood / Q000601:surgery*; D008875:Middle Aged; D009215:Myometrium / Q000601:surgery*; D014590:Uterine Contraction / Q000187:drug effects; D014594:Uterine Neoplasms / Q000097:blood / Q000601:surgery*
C016767:sulprostone; D015232:Dinoprostone
Possibilità d'impiego del sulprostone in corso di laparomiomectomia nella fibromiomatosi uterina. Indagini preliminari.